BD Receives FDA 510(k) Clearance for Updated BD Alaris™ Infusion System
Go back to BD Receives FDA 510(k) Clearance for Updated BD Alaris™ Infusion System| Becton Dickinson (NYSE: BDX) | Delayed: 181.96 -1.04 (0.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $183.00 | 52 Week High | $181.76 | |||
| Open | $182.10 | 52 Week Low | $129.50 | |||
| Day High | $184.37 | P/E | 38.80 | |||
| Day Low | $181.31 | EPS | $4.69 | |||
| Volume | 547,406 | |||||
